Savient Pharmaceuticals (NASDAQ:SVNT) sees its price target raised by William Blair after the latter hosted an investor meeting with the firm’s management in New York. Blair points to Krystexxa price increase assumptions for the elevated target and maintains its Outperform.
Yum! Brands (NYSE:YUM) is experiencing increasing growth in profits along with seeing its sales in China becoming more stable. UBS thinks that these factors, with a growth of 6 percent in same-store-sales in that country, should drive the company’s shares which are rated Buy with a price target of $81.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Hewlett-Packard Company’s (NYSE:HPQ) break-up is considered to be more likely by UBS, which thinks that the firm should be divided into enterprise and PC/printers. Based on a sum-of-the-parts analysis, UBS calculates that shares are worth $20 for which the analyst has a Sell rating with a target of $14, citing recent underperformance and lack of willingness to conduct near-term structural changes by the management.
BioMarin Pharmaceutical (NASDAQ:BMRN) shares are being recommended by RBC Capital into the upcoming release of Phase III GALNS data and buying more on weakness if the data are mixed or negative is also suggested. RBC thinks the stock should recover from any weakness over the long term, based on the firm’s pipeline. An Outperform rating is being maintained.
Foot Locker’s (NYSE:FL) recent weakness prior to October sales is the basis upon which UBS recommends buying shares,as it believes that basketball sales should take off again in this month due to new launches. A Buy is thus maintained along with a price target of $38.
Don’t Miss: This Apple Bull is Raging Against Naysayer.